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Summary
Background: The left ventricular hypertrophy (LVH) is an important and independent cardiovascular risk factor. There 
is a scarcity of studies in Brazil designed to test the efficacy of the electrocardiogram (ECG) in the diagnosis of this 
important pathological process. 
Objective: To evaluate a new electrocardiographic score for the diagnosis of LVH by ECG: the sum of the highest 
amplitude of the S wave and the highest amplitude of the R wave on the horizontal plane, multiplied by the result of the 
QRS duration [(S+R) X QRS)] and comparing it with the classic electrocardiographic criteria.
Methods: The echocardiograms and ECG of 1,204 hypertensive patients receiving outpatient care were evaluated. The 
left ventricular mass index (LVMI) was assessed by the echocardiogram, with a diagnosis of LVH when the LVMI was ≥ 
96 g/m2 for women and ≥ 116 g/m2 for men. Four classic criteria of LVH were analyzed at the ECG, in addition to the 
new score to be tested.
Results: In general, the studied ECG-LVH criteria showed significant statistical correlation to the echocardiographic 
LVMI. The (R+S) X QRS index, using 2.80 mm.s as the cutoff value, provided test accuracy regarding sensibility and 
specificity of 35.2% and 88.71%, respectively, representing the best correlation to LVMI (r=0.564) when compared 
to the other indexes: Romhilt-Estes (r=0.464); Sokolow-Lyon (r=0.419); Cornell voltage (r=0.377); Cornell product 
r=0.444).
Conclusion: All the electrocardiographic criteria used for the assessment of the LV mass presented low sensitivity. The 
new score presented the best correlation with LVMI when compared to the other indexes. (Arq Bras Cardiol 2008; 90(4): 
227-231)
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Introduction
The left ventricular hypertrophy (LVH) represents an important 
cardiovascular risk factor, independent from the systemic arterial 
hypertension (SAH), one of its main causes1,2.
Among the several propedeutic methods for the diagnosis 
of LVH, the least expensive, most broadly disseminated and 
easier to interpret method is the electrocardiogram (ECG), 
which presents high specificity, although it has low diagnosis 
sensitivity. However, in spite of this limitation, it remains a 
broadly used complementary test in medical practice as well 
as in population studies, in the prevention as well as in the 
analysis of regression of the hypertrophic process3,4.
Additionally, the ECG presents excellent reproducibility, 
being very useful in the clinical follow-up of the patients. The 
development of studies in SAH and valvulopathies has given 
rise to several electrocardiographic criteria for the detection 
of LVH, with variable sensitivities and specificities, depending 
on the studied population. These criteria, some with simpler 
applicability, others with a more complex one, have been 
used and correlated with methods of better accuracy in the 
assessment of the left ventricular mass (LVM), such as magnetic 
resonance and especially, the echocardiogram5,6.
However, the variability of the results in the studied 
populations is related to demographic aspects, such as 
gender, race, age and associated heart pathology. There is no 
record of such a study, in our country, that has evaluated the 
efficacy of the ECG in the diagnosis of LVH, which is relevant 
information, considering that our population has a high rate 
of miscegenation and must have its own characteristics of 
electrocardiographic presentation and response, regarding 
the sensitivity and specificity of the several criteria used to 
detect LVH. 
The objective of this study is to evaluate a new 
electrocardiographic score for the detection of LVH in the 
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Transthoracic Echocardiogram 
The assessments were carried out at the Service of Doppler 
Echocardiography of UNIFESP-EPM in an ATL 1500 equipment 
(USA), using a 2.0 and a 3.5 MHz transducers. The patients 
was placed on the left lateral decubitus position and the images 
were obtained from the left parasternal region between the 
fourth or fifth intercostal spaces and the usual views were 
obtained for the complete M-mode and two-dimensional 
study, simultaneously with the ECG register. According to 
the recommendations of the Penn Convention, the following 
measurements were performed: size of the LV in systole 
and diastole, thickness of the interventricular septum and of 
the posterior wall of the LV at the end of the diastole, final 
diastolic and systolic volumes, diastolic shortening percentage 
and ejection fraction by the cube method. The left ventricular 
mass was calculated by the formula: LV mass = 0.8 X {1.04 
[(IVSD + LVDD + PLVWD)3 – (DDVE)3]} + 0.6 g13, where 
IVSD is the interventricular septum in diastole, LVDD is the 
final left ventricular diastolic diameter and PLVWD is the 
posterior LV wall in diastole. The LV mass was indexed for body 
surface area to adjust the differences of the heart size to the 
variations in patient size. Body surface area was calculated by 
the formula: BSA = (W – 60) X 0.01 + H, where BSA is the 
body surface area in m2, W is the weight in kilograms and H is 
height in meters14. The body mass index (BMI) was calculated 
by dividing the weight (in kilograms) by the square height (in 
meters). The diagnosis of LVH was attained when the LVMI 
was ≥ 96 g/m2 for women and ≥ 116 g/m2 for men15. 
Statistical Analysis 
Continuous variables were expressed as means and 
standard deviations. Categorical variables were expressed 
as percentages. Pearson’s correlation coefficient was used to 
associate LVMI and the several electrocardiographic criteria 
that were analyzed. The ROC curve was used to validate the 
new score proposed here and a cutoff that presented better 
sensitivity and specificity was established. The reproducibility 
study was carried out by three observers that interpreted the 
ECG assessments independently. The Kappa test was used to 
analyze the several ECG variables16. This test is a measurement 
index for nominal or categorical variables that corrects the 
observed concordance for the expected one, only due to 
a matter of probability. Values > 0.75 are considered to be 
excellent; those below 0.40 show poor concordance and those 
between 0.40 and 0.75 show good concordance. In order to 
verify the statistical significance, 95% confidence intervals and 
p < 0.01 were considered.
Results
Of the 1,204 patients studied, 617 were males (51.2%) 
and 587 were females (48.8%), with a mean age of 57.4 ± 
4.7 years.
Table 1 shows Pearson’s correlation among the several 
assessed electrocardiographic criteria and LVMI. The table 
shows that the new score is the one that maintains the best 
performance.
Table 2 shows the same Pearson’s correlation among the 
assessed electrocardiographic criteria and the LVMI in the 
Brazilian population, in a sample consisting of hypertensive 
individuals being followed on an outpatient basis and compare 
it with some of the classical ECG criteria used for the diagnosis 
of LVH, using the LVMI as the gold standard for the analysis.
Methods
Patients
The ECG tracings of 1,204 patients with SAH being 
followed on an outpatient basis were assessed at the Service 
of Hypertensive Cardiology of Universidade Federal de São 
Paulo - Escola Paulista de Medicina (UNIFESP-EPM) from 
March 1998 to December 2003. All of the ECG tracings 
were assessed according to the recommendations of the Iv 
Brazilian Directives of Arterial Hypertension7, i.e., at least two 
blood pressure measurements per medical visit on at least 
two different occasions, with SAH being diagnosed when 
the means of the measurements were ≥ 140 mmHg for the 
systolic pressure and 90 mmHg for the diastolic pressure. The 
exclusion criteria included: neoplasias, patients with valvular 
disease, acute coronary artery disease, previous myocardial 
infarction, Chagas’ disease, blockage of the right or left branch, 
ventricular preexcitation syndrome or any other condition that 
could potentially disturb the LV geometry. 
Electrocardiogram
A resting ECG was carried out with the patient in the supine 
position and the 12-derivation ECG was obtained with a register 
velocity of 25 mm/s, calibration standardized at 1.0 mV/cm in 
a Dixtal EP3 equipment, Brazil. The tracing was decodified 
and a magnifying glass with a mm scale was used to analyze 
the several variables, which allowed a more precise analysis. 
The same observer quantified the axis and the duration of the 
QRS complex, the amplitude of the R wave at the D1, aVL, V5 
and V6 derivations, amplitude of the S wave at V1, V2 and V3, 
as well as the higher amplitude of the R and S waves at the 
horizontal derivations. Five electrocardiographic criteria of 
LVH were separately assessed: 1) Romhilt-Estes point score 
system – higher R amplitude or S ≥ 30 mm on the horizontal 
plane or ≥ 20 mm on the frontal plane or strain pattern in V5 
or V6 (when using digital, the score is only one point), or left 
atrial growth by the Morris index (three points); electrical axis 
(ÂQRS) above less than 30o (two points); QRS duration ≥ 90 
ms in V5 or V6 or left ventricular activation time ≥ 50 ms in 
V5 or V6 (one point). Using this score, the LVH is diagnosed 
when the sum of the points is ≥ 58; 2) Sokolow-Lyon voltage 
(SV1 + RV5 or V6 ≥ 35 mm)
9; 3) Cornell’s voltage (RaVL + SV3 
≥ 20 mm for women and ≥ 28 mm for men)10; 4) Cornell’s 
duration (RaVL + SV3 X QRS duration; for women add 8 mm, 
≥ 2,440 mm.ms)11; 5) Perugia score – LVH is diagnosed by the 
presence of one or more of the following findings: Cornell’s 
criterion, considering the limit for women ≥ 20 mm and ≥ 
24 mm for men, Romhilt-Estes score and the strain pattern12. 
The new score proposed here takes into account the higher 
amplitude of the R or S waves on the horizontal plane (in mm), 
multiplying the value obtained by the QRS measurement (in 
seconds) where the complex is broader, usually in V2 and V3. 
The analysis of reproducibility was carried out based on 100 
tracings randomly withdrawn for the analysis of the amplitude 
of the R and S waves and QRS duration. 
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general population, separating the patients in two groups: 
non-obese (BMI < 30 Kg/m2), or 852 patients (70.7%) and 
obese patients (BMI > 30 Kg/m2), a group represented by 352 
patients (29.3% of the sample). As expected, among the obese 
patients the correlation between the ECG criteria and the LVMI 
decrease in general17. However, the new score is once more 
the one that presents the best performance.
Table 3 shows the sensitivity and specificity values of the 
new score, which was obtained from the ROC curve and 
the cutoff of 2.8 mm.s was arbitrarily used for the diagnosis 
of LVH. 
Table 4 shows the values of sensitivity, specificity and 
accuracy of the five electrocardiographic criteria assessed, as 
well as of the new score proposed here, based on the assessed 
sample that consisted of 1,204 hypertensive individuals.
Regarding reproducibility, the level of concordance among 
the three observers varied from 0.82 to 0.98, considered to be 
an excellent level of concordance. The first value corresponds 
to duration of the QRS complex and the last to the amplitude 
of the R and S waves.
Discussion
This study was carried out using the echocardiogram as the 
gold standard for the diagnosis of LVH. It is unquestionable 
that this imaging procedure represents a great advancement 
in the diagnosis of several heart pathologies, including LVH. 
However, its cost is quite higher than that of the ECG, as 
well as being less reproducible, as it depends very much on 
the observer, a fact that restricts its use in epidemiological 
studies. 
On the other hand, studies that used the anatomical 
specimen obtained during the necropsy as the gold standard 
of LVH8,18 presented higher distortions, as depending on the 
time and clinical condition of the patient before death, there 
can be a relevant bias. 
Thus, considering its low cost and excellent reproducibility, 
the ECG is still important for the diagnosis of LVH, which is 
why it has been broadly used in clinical studies that involve 
SAH and LVH3,19,20. The same reason justifies and encourages 
the research of new electrocardiographic methods capable of 
increasing its diagnostic sensitivity. 
In 1967, Romhilt and Estes8 studied 90 hypertrophied 
hearts and 60 normal hearts. The specimens were obtained 
during necropsies and the ECG tracings had been performed at 
least 3 months before death. The sensitivity and the specificity 
of the original study were 57.8% and 96.7%, respectively. In 
the present sample, the specificity value is similar; however, 
the sensitivity value is much lower (15.3%), with Pearson’s 
correlation with the LVMI being 0.464.
Table 1 - Correlation between the LMI and the assessed electrocardiographic criteria.
Statistical Test
Electrocardiographic criterion
Romhilt-Estes Sokolow-Lyon Cornell-voltage Cornell-duration New score (mS+mR).QRS
Pearson’s correlation 0.464* 0.419* 0.377* 0.444* 0.564*
p value 0.001 0.001 0.001 0.001 0.001
N 1,204 1,204 1,204 1,204 1,204
*Significant correlation at 0.01 level (two-tailed)
Table 2 - Correlation between the LVMI and the assessed electrocardiographic criteria, analysis of the general population and the obese and 
the non-obese groups.
Population
Electrocardiographic criterion / Pearson’s correlation
Romhilt-Estes Sokolow-Lyon Cornell-voltage Cornell-duration New score
General population (n = 1,204) 0.464* 0.419* 0.377* 0.444* 0.564*
Non-obese (n = 852) 0.500* 0.458* 0.385* 0.462* 0.606*
Obese (n = 352) 0.326* 0.285* 0.359* 0.392* 0.420*
*p < 0.01.
Table 3 - Sensitivity and specificity of the new score, according to 
the cutoff value calculated by the ROC curve.
Cutoff value 
(mS+mR).QRS Sensitivity (%) Specificity (%)
≥ 2.50 mm.s 45.4 82.5
≥ 2.60 mm.s 40.9 83.9
≥ 2.70 mm.s 38.4 86.2
≥ 2.80 mm.s 35.2 88.7
≥ 2.90 mm.s 31.5 90.1
≥ 3.00 mm.s 28.1 91.7
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The publication of the Sokolow-Lyon voltage criterion9 
dates from 1949 and is still very often used in clinical practice, 
given its easy applicability. In the original study, the authors 
studied 200 patients with some heart disorder capable 
of causing LV stress. The sensitivity and specificity values 
observed were 32% and 96%, respectively; it is important to 
note that it was a selected sample.  In the present population, 
the specificity was very high (96.8%), although the sensitivity 
decreased to 13.4%. 
In the present study, the Cornell voltage criterion10 
presented a sensitivity of 22.2% and specificity of 96.8%. 
The results were similar regarding the specificity; however, 
the difference was significant regarding the sensitivity (42% 
vs. 22.2%). Additionally, Pearson’s correlation for the same 
criterion was 0.377, much lower than that of the new score, 
of 0.564.
Regarding the Cornell duration criterion11, Pearson’s 
correlation was higher (r=0.444), suggesting that the methods 
that also take into account the duration of the ventricular 
depolarization, such as the new score, can be more reliable.
Schillaci et al12, in 1994, using the Perugia score for the 
diagnosis of LVH in the PIUMA study, found a sensitivity of 
26% and a specificity of 90%. When testing this same score 
in the present sample, a sensitivity of 38.6% and a specificity 
of 89.6% were observed. It was not possible to carry out 
Pearson’s correlation between the Perugia score and the LVMI, 
considering that it was the score of a qualitative variable.
It is noteworthy that Pearson’s correlation among all the 
electrocardiographic criteria assessed with the LVMI lost 
its strength, as expected, in the group of obese patients17. 
However, the new score presented here also showed a better 
performance in this group.
Conclusion
The ECG is a safe, accessible, low-cost complementary test 
with an excellent reproducibility. Thus, the search for new 
criteria capable of increasing its diagnostic sensitivity in the 
detection of LVH must be stimulated and encouraged. The 
new score proposed here, of which cutoff for the diagnosis 
of LVH was arbitrarily set at 2.8 mm.s, is easily applicable in 
clinical practice and presented the best correlation with the 
LVMI, when compared to some classic electrocardiographic 
criteria, as well as presenting the best attenuation in the group 
of obese patients.
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Table 4 – Sensitivity, specificity and accuracy of the classic electrocardiographic scores and the new score in the diagnosis of LVH.
Criterion Sensitivity (%) Specificity (%) Accuracy (%)
Romhilt-Estes ≥ 5 points 16.3 95.8 66.7
Sokolow-Lyon (mm)
(SV1+RV5-6) ≥ 35 
13.4 96.8 66.3
Cornell voltage (mm)
RaVL+ SV3 > 28 when male or 20 when female
18.8 96.8 68.3
Cornell duration (mm.ms)
(RaVL+ SV3 + 8 when female) x QRS > 2440 
22.2 96.0 69.0
Perugia
Strain pattern or Romhilt-Estes ≥ 5 points or RaVL+ SV3  > 24 mm 
when male or 20 mm when female 
38.6 89.6 71.0
New score (mS+mR) x QRS ≥ 2.8 mm.s 35.2 88.7 68.7
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